research Distinguishing Mouse Strains by Proteomic Analysis of Pelage Hair
Proteomic analysis can identify genetic differences in mouse hair, helping understand hair defects and variations.
Search
forResearch
5 / 933 results
research Ficoll density gradient sedimentation isolation of pelage hair follicle mesenchymal stem cells from adult mouse back skin: a novel method for hair follicle mesenchymal stem cells isolation
This study found that a large number of pelage hair follicle mesenchymal stem cells can be efficiently isolated using two-step Ficoll Density Gradient Sedimentation, promoting hair growth by secreting exosomes in mice.
research Ficoll density gradient sedimentation isolation of pelage hair follicle mesenchymal stem cells from adult mouse back skin: A novel methods for hair follicle mesenchymal stem cells isolation.
This study reported that pelage hair follicle mesenchymal stem cells isolated from mice using Ficoll Density Gradient Sedimentation can be obtained in large numbers and may promote hair growth via exosome secretion.
research Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin
This study found that follistatin and activin interactions are important for hair follicle development and cycling in mice, suggesting that they may regulate processes involving BMP-2 and its antagonist.
research Cross-linked features of mouse pelage hair resistant to detergent extraction
This study found that defective cross-linking in hair cuticles is observable in a minority of mouse hair mutants, suggesting different proteins are involved in cross-linking across cell types.
Community Join
5 / 214 resultscommunity Track hairline of Pelage executives
Pelage executives' hairlines were discussed, with speculation about them using PP405 for hair regrowth. Concerns were raised about using untested drugs, with some suggesting executives might not risk using them without safety data.
community Pelage curing hair loss with PP405 could become one of the most famous discoveries in history
PP405 is discussed as a potential treatment for hair loss, with excitement about its promise but skepticism about its current effectiveness. Users mention combining it with treatments like minoxidil, finasteride, and microneedling, but emphasize it is not a cure.
community Pelage PP405: New Hair Growth from Inactive Follicular Units - Phase 2a results at AAD 2026
PP405, a topical treatment, shows promise for hair growth by activating inactive follicles, with 66% of participants experiencing positive results. The treatment is well-tolerated and may proceed directly to Phase 3 trials, offering a potential alternative to minoxidil and finasteride.
community Will Pelage include Norwood 7 hair loss in PP405 phase 3 trials to see its true regenerative potential?
Norwood 7 hair loss is often excluded from trials to ensure treatments appear more effective and to reduce costs. Some believe treatments effective for Norwood 5 could work on Norwood 7, but companies prioritize market readiness.
community Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy
Pelage Pharmaceuticals announced positive Phase 2a trial results for PP405 in hair loss therapy. The conversation discusses the delay in publishing full results and the need for further trials and approvals.
Learn
1 / 801 results- Got small bald patches they say are from stress? PP405 sprays could help bring them back to life. PP405 is an experimental topical gel from Pelage Pharmaceuticals that inhibits the mitochondrial pyruvate carrier; its registered Phase 2 trial (NCT06393452) tested it once daily in 78 adults with pattern hair loss, for safety and tolerability. It is not approved, not for sale, and has not been studied in alopecia areata or stress-related shedding.
- Did you know PP405 peptides can help protect your follicles from DHT? PP405 is not a peptide and does not block DHT: it is an experimental topical gel from Pelage Pharmaceuticals that inhibits the mitochondrial pyruvate carrier, aimed at waking dormant follicles. Its registered Phase 2 trial (NCT06393452) measured safety and tolerability in 78 adults with pattern hair loss; it is not approved and not for sale.
learn PP405
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
Clinics
6 / 500 results- 49
Hair Loss TreatmentsSMPHair Transplant360 Hair ClinicBrighton, England · GB - 66
Hair TransplantAEK Hairİstanbul · TR - 59
Hair TransplantAKESO Hair Transplant and Plastic SurgeryNew Delhi, Delhi · IN - 25
Hair SystemsALARA hair solutionsBurnaby, BC · CA - 63Hair TransplantANAGEN – Hair Transplant by Centre Esthétique des CanutsLyon · FR
- 48Hair TransplantAPERA HairAtasehir · TR
Experts
5 / 136 results- 35Dermatologist
Dr. Divya Hairdas, MD, MBBS
Dubai, United Arab Emirates
- 50Hair Loss Specialist
HairvoyageTurkey
Incomplete name
Antalya, Türkiye
- 48Hair Loss Specialist
Hairmo
Incomplete name
Ampang, Selangor, Malaysia
- UnscoredSMP Specialist
Hairo Fallas
Newark, NJ, United States
- 12Hair Loss Specialist
Hairaid
Incomplete name
Florence, Italy